# Nuclide record bracco (company). Data CC BY-NC 4.0, attribute "Data from Nuclide (nuclide.cc)". Whole corpus: https://nuclide.cc/api/v1/nuclide.nt
@prefix schema: <https://schema.org/> .
@prefix nuclide: <https://nuclide.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://nuclide.cc/companies/bracco/>
  a schema:Organization ;
  nuclide:kind "company" ;
  schema:identifier "bracco" ;
  schema:name "Bracco Imaging"@en ;
  schema:alternateName "Bracco Imaging S.p.A."@en, "Bracco Group"@en ;
  schema:description "An Italian company that makes the dyes and tracers doctors use to see inside the body on X-ray, CT, MRI, ultrasound and PET/SPECT scans, and, through a subsidiary, some of the radioactive scans used to find prostate cancer."@en ;
  schema:url <https://nuclide.cc/companies/bracco/>, <https://www.bracco.com> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://www.bracco.com/en-us/our-portfolio>, <https://www.bracco.com/our-businesses>, <https://www.bracco.com/en-us/oncology>, <https://www.fiercebiotech.com/medtech/blue-earth-diagnostics-sold-to-bracco-imaging-450m-deal>, <https://www.bracco.com/article/bracco-imaging-expands-its-portfolio-personalized-diagnostics> ;
  nuclide:status "active" ;
  nuclide:tag "contrast media", "diagnostics", "prostate cancer imaging" ;
  schema:addressCountry "IT" ;
  nuclide:related <https://nuclide.cc/companies/blue-earth-diagnostics/>, <https://nuclide.cc/drugs/fluciclovine-f18/>, <https://nuclide.cc/targets/psma/>, <https://nuclide.cc/indications/prostate/>, <https://nuclide.cc/technologies/psma-pet/>, <https://nuclide.cc/isotopes/f-18/>, <https://nuclide.cc/isotopes/lu-177/> .